Global Blood CEO Speaks on Rising Sales, Diversity in Trials

(Bloomberg) -- Global Blood Therapeutics Inc. Chief Executive Officer Ted Love says his company’s new treatment for sickle cell disease is already seeing a steady stream of prescriptions since its ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.